Review of (90)Y-ibritumomab tiuxetan as first-line consolidation radio-immunotherapy for B-cell follicular non-Hodgkin’s lymphoma

Several studies have indicated that radioimmunotherapy is an effective and clinically relevant complementary therapeutic approach for patients with B-cell non-Hodgkin’s lymphoma (NHL) and may convert partial to complete response when given as consolidation after induction chemotherapy. Yttrium-90((9...

Descripción completa

Detalles Bibliográficos
Autor principal: Emmanouilides, Christos
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004670/
https://www.ncbi.nlm.nih.gov/pubmed/21188131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004670/
https://www.ncbi.nlm.nih.gov/pubmed/21188131

Ejemplares similares